Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | HALO | EXEL | ||
| Company | Blueprint Medicines Corp | Halozyme Therapeutic | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 115.90 | 56.08 | 23.09 | ||
| High | 116.51 | 57.08 | 23.50 | ||
| Low | 112.02 | 55.63 | 22.80 | ||
| Last | 112.19 | 56.23 | 23.39 | ||
| Change | -1.50 | +0.26 | +0.43 | ||
| % Change | -1.32% | +0.46% | +1.87% | ||
| Volume | 435,500 | 831,900 | 1,693,600 | ||
| 20-Day Average Volume | 635,200 | 1,290,015 | 1,326,735 | ||
| Previous Close | 113.69 | 55.97 | 22.96 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 114.43 | 53.57 | 22.45 | ||
| 20-Day Raw Stochastic | 40.72% | 86.65% | 93.45% | ||
| 20-Day Relative Strength | 52.41% | 70.26% | 64.14% | ||
| Weighted Alpha | +88.97 | +47.57 | +16.66 | ||
| Today's Opinion | 88% Buy | 100% Buy | 56% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.42% since 07/19/24 | +4.05% since 07/19/24 | +3.50% since 07/19/24 | ||
| Low | 112.02 on 07/26/24 | 53.13 on 07/22/24 | 22.20 on 07/24/24 | ||
| High | 118.91 on 07/23/24 | 57.08 on 07/26/24 | 23.50 on 07/26/24 | ||
| 1-Month | |||||
| %Chg | +7.96% since 06/26/24 | +8.13% since 06/26/24 | +4.51% since 06/26/24 | ||
| Low | 103.01 on 06/27/24 | 50.68 on 07/02/24 | 21.82 on 07/03/24 | ||
| High | 121.90 on 07/16/24 | 57.08 on 07/26/24 | 23.50 on 07/26/24 | ||
| 3-Month | |||||
| %Chg | +20.63% since 04/26/24 | +45.79% since 04/26/24 | -1.31% since 04/26/24 | ||
| Low | 90.75 on 04/30/24 | 37.97 on 04/30/24 | 20.14 on 05/29/24 | ||
| High | 121.90 on 07/16/24 | 57.08 on 07/26/24 | 23.89 on 04/29/24 | ||
| 6-Month | |||||
| %Chg | +37.56% since 01/26/24 | +64.37% since 01/26/24 | +5.74% since 01/26/24 | ||
| Low | 72.24 on 02/14/24 | 33.15 on 02/05/24 | 20.01 on 02/12/24 | ||
| High | 121.90 on 07/16/24 | 57.08 on 07/26/24 | 24.07 on 03/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,118,927 | 7,123,526 | 6,961,472 | ||
| Shares Outstanding, K | 62,617 | 127,274 | 303,200 | ||
| Annual Sales | 249,380,000 | 829,250,000 | 1,830,210,000 | ||
| Annual Net Income | -506,980,000 | 281,590,000 | 207,770,000 | ||
| Last Quarter Sales | 96,120,000 | 195,880,000 | 425,230,000 | ||
| Last Quarter Net Income | 89,140,000 | 76,820,000 | 37,320,000 | ||
| 60-Month Beta | 0.63 | 1.27 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.32 on 05/02/24 | 0.79 on 05/07/24 | 0.17 on 04/30/24 | ||
| Latest Earnings Date | 08/01/24 | 08/06/24 | 08/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.49 | 34.92 | ||